Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis

IMPORTANCE: Cardiovascular adverse events (CVAE) with carfilzomib in patients with multiple myeloma can be potentially life-threatening and remain incompletely characterized. We performed the first systematic review and meta-analysis of carfilzomib-associated CVAE. OBJECTIVE: To determine the incide...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Waxman, Adam J., Clasen, Suparna, Hwang, Wei-Ting, Garfall, Alfred, Vogl, Dan T., Carver, Joseph, O’Quinn, Rupal, Cohen, Adam D., Stadtmauer, Edward A., Ky, Bonnie, Weiss, Brendan M.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2017
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885859/
https://ncbi.nlm.nih.gov/pubmed/29285538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.4519
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars